BR112016000316A8 - uso de fibroblasto gengival no tratamento de alopecia - Google Patents

uso de fibroblasto gengival no tratamento de alopecia

Info

Publication number
BR112016000316A8
BR112016000316A8 BR112016000316A BR112016000316A BR112016000316A8 BR 112016000316 A8 BR112016000316 A8 BR 112016000316A8 BR 112016000316 A BR112016000316 A BR 112016000316A BR 112016000316 A BR112016000316 A BR 112016000316A BR 112016000316 A8 BR112016000316 A8 BR 112016000316A8
Authority
BR
Brazil
Prior art keywords
alopecia
treatment
gingival fibroblasts
gingival
relates
Prior art date
Application number
BR112016000316A
Other languages
English (en)
Other versions
BR112016000316A2 (pt
Inventor
Lafont Antoine
Coulomb Bernard
Linard Christine
Lataillade Jean-Jacques
Original Assignee
Hopitaux Paris Assist Publique
Etat Francais Mini De La Defense Direction Centrale Du Service De Sante Des Amees
Inst De Radioprotection Et De Surete Nucleaire
Inst Nat Sante Rech Med
Univ Paris Descartes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hopitaux Paris Assist Publique, Etat Francais Mini De La Defense Direction Centrale Du Service De Sante Des Amees, Inst De Radioprotection Et De Surete Nucleaire, Inst Nat Sante Rech Med, Univ Paris Descartes filed Critical Hopitaux Paris Assist Publique
Publication of BR112016000316A2 publication Critical patent/BR112016000316A2/pt
Publication of BR112016000316A8 publication Critical patent/BR112016000316A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

resumo “uso de fibroblasto gengival no tratamento de alopecia” a presente invenção refere-se ao uso de produtos derivados de fibroblastos gengivais para reduzir a queda de cabelo e promover o crescimento de cabelos. es-pecificamente, a invenção refere-se a um produto derivado a partir de fibroblastos gengivais para serem usados no tratamento ou prevenção de alopecia, assim como na promoção de crescimento de cabelo natural e/ou no controle de queda de cabelo natural.
BR112016000316A 2013-07-09 2014-07-09 uso de fibroblasto gengival no tratamento de alopecia BR112016000316A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1356740A FR3008316B1 (fr) 2013-07-09 2013-07-09 Utilisation de fibroblastes gingivaux dans le traitement de l'alopecie
PCT/EP2014/064772 WO2015004216A1 (fr) 2013-07-09 2014-07-09 Utilisation de fibroblastes gingivaux dans le traitement de l'alopecie

Publications (2)

Publication Number Publication Date
BR112016000316A2 BR112016000316A2 (pt) 2017-08-22
BR112016000316A8 true BR112016000316A8 (pt) 2018-01-23

Family

ID=49713155

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016000316A BR112016000316A8 (pt) 2013-07-09 2014-07-09 uso de fibroblasto gengival no tratamento de alopecia

Country Status (10)

Country Link
US (2) US10624838B2 (pt)
EP (1) EP3019179B1 (pt)
JP (2) JP6595464B2 (pt)
KR (1) KR20160035586A (pt)
AU (1) AU2014289243A1 (pt)
BR (1) BR112016000316A8 (pt)
CA (1) CA2917283C (pt)
ES (1) ES2864328T3 (pt)
FR (1) FR3008316B1 (pt)
WO (1) WO2015004216A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110267668A (zh) * 2016-11-18 2019-09-20 思卡赛尔治疗公司 可用于治疗免疫相关疾病的组合物
AU2022281340A1 (en) * 2021-05-26 2024-01-04 Figene, Llc Methods and compositions for alopecia treatment using fibroblasts and fibroblast-derived products
CN114917250A (zh) * 2022-05-06 2022-08-19 广东发亿科技有限公司 成纤维细胞外囊泡hFB-EVs在治疗脱发产品中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04224522A (ja) * 1990-04-27 1992-08-13 Merck & Co Inc 繊維芽細胞増殖因子含有組成物による禿頭症の治療又は予防方法
US7799325B2 (en) * 1999-11-05 2010-09-21 Kleinsek Donald A Removal of hypertrophic scars
FR2872431B1 (fr) 2004-07-02 2007-07-20 Univ Rene Descartes Paris V Et Utilisation de fibroplastes gingivaux en therapie cellulaire vasculaire
JP4565112B2 (ja) * 2004-09-15 2010-10-20 独立行政法人産業技術総合研究所 毛髪成長促進剤、発毛促進剤及び脱毛症治療剤
JP2006131600A (ja) * 2004-11-09 2006-05-25 R & D Cell-Science Optional Medico:Kk 発毛促進のためのヒト細胞組成物
JP4982865B2 (ja) * 2005-06-29 2012-07-25 国立大学法人名古屋大学 皮膚組織改善材及びその利用
US8303948B2 (en) * 2006-08-10 2012-11-06 Universite Paris Descartes Method for treating skin wounds
US7951593B2 (en) 2007-03-20 2011-05-31 Universite Rene Descartes-Paris V Culture medium for gingival fibroblasts
US8208189B2 (en) 2007-04-13 2012-06-26 Reliant Technologies, Inc. Treatment of alopecia by micropore delivery of stem cells
US8535913B2 (en) * 2008-01-30 2013-09-17 Histogen, Inc. Soluble composition for promoting hair growth produced by hypoxic culture of fibroblasts cells
EP2105499A1 (en) * 2008-03-28 2009-09-30 Technische Universität Berlin Methods for producing de novo papillae and hair microfollicles and their use for in vitro tests and in vivo implantations
DK2257272T3 (da) * 2008-03-31 2014-01-20 Scarcell Therapeutics Fremgangsmåde til kosmetisk behandling af fotoaldring i hud
CN102747033A (zh) 2012-06-26 2012-10-24 亚太干细胞科研中心有限公司 一种由牙龈组织培养间充质干细胞和成纤维组织的方法

Also Published As

Publication number Publication date
KR20160035586A (ko) 2016-03-31
US20200306174A1 (en) 2020-10-01
JP2016523948A (ja) 2016-08-12
BR112016000316A2 (pt) 2017-08-22
AU2014289243A1 (en) 2016-01-28
CA2917283C (fr) 2021-11-16
JP6595464B2 (ja) 2019-10-23
WO2015004216A1 (fr) 2015-01-15
JP2019142965A (ja) 2019-08-29
EP3019179B1 (fr) 2021-01-13
US20160151274A1 (en) 2016-06-02
CA2917283A1 (fr) 2015-01-15
EP3019179A1 (fr) 2016-05-18
ES2864328T3 (es) 2021-10-13
FR3008316A1 (fr) 2015-01-16
US10624838B2 (en) 2020-04-21
FR3008316B1 (fr) 2020-01-31

Similar Documents

Publication Publication Date Title
AU2018256635A1 (en) Methods for treating anemia
MX2016009852A (es) Sistemas para el cuidado de la piel despues del procedimiento, composiciones y metodos de uso de los mismos.
WO2012163869A3 (en) Composition comprising an alkoxysilane and a modified starch, and cosmetic use thereof
MX2016005585A (es) Exopolisacarido para el tratamiento y/o el cuidado de la piel, medios de cultivo y composiciones del mismo.
MX362488B (es) Composiciones y metodos para tratar la perdida del cabello y retrasar el envejecimiento de la piel.
MX2013006023A (es) Exopolisacarido para el tratamiento y/o cuidado de piel, mucosas, cabello y/o uñas.
IN2015DN02938A (pt)
MX2017014253A (es) Metodos y composiciones para promover el crecimiento del cabello.
EA201492040A1 (ru) Бициклически замещённые урацилы и их применение
TR201902440T4 (tr) Alopesi tedavisine yönelik farmasötik ya da kozmetik bileşim.
BR112015024846A2 (pt) composições para utilização no estímulo do crescimento ósseo
MY184372A (en) Methods and compositions for wound healing
WO2013174774A3 (en) Cosmetic compositions comprising magnetosomes and uses thereof
BR112014002595A2 (pt) uso de esfinganina para melhorar a aparência visual da pele e cabelo
WO2012076109A3 (de) 2-pyrone
BR112016001919A2 (pt) composição cosmética e processo de tratamento cosmético
WO2013190567A3 (en) Composition and method for an intradermal hair growth solution
BR112016000316A8 (pt) uso de fibroblasto gengival no tratamento de alopecia
BR112018012355A2 (pt) composição dermocosmética, processo de produção da composição tópica, método para fortalecimento de unhas frágeis e uso da composição
BR112016002461A2 (pt) processo para o tratamento das fibras queratínicas e uso de um composto
EP2596787A4 (en) NEW USE OF HESPERETIN
GB2490854A (en) Method of treatment or prevention of hair loss or for the enhancement of hair growth
MX2016006544A (es) Witanolidos utiles para el tratamiento de enfermedades neurodegenerativas.
MX2013012967A (es) Composicion de miel con l-alanil-l-glutamina.
WO2015112866A3 (en) Compounds and methods for increasing hair growth

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2522 DE 07-05-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.